Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.88%
1,100.61
-9.73
-0.88%
1,110.341,110.371,117.241,097.84
SIXC
Communications
SIXC
Communications
SIXC
-1.33%
612.30
-8.24
-1.33%
620.54620.54622.67611.42
SIXE
Energy
SIXE
Energy
SIXE
+1.40%
1,175.46
+16.26
+1.40%
1,159.201,160.591,177.621,156.21
SIXI
Industrials
SIXI
Industrials
SIXI
-1.39%
1,729.12
-24.32
-1.39%
1,753.441,749.081,762.011,724.74
SIXM
Financials
SIXM
Financials
SIXM
-0.63%
644.73
-4.07
-0.63%
648.80649.58655.73643.68
SIXR
Staples
SIXR
Staples
SIXR
-0.65%
827.09
-5.40
-0.65%
832.49832.07833.09826.15
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-1.98%
214.82
-4.34
-1.98%
219.16219.16219.19214.82
SIXT
Technology
SIXT
Technology
SIXT
+0.06%
3,115.17
+1.81
+0.06%
3,113.363,120.793,143.643,105.16
SIXU
Utilities
SIXU
Utilities
SIXU
-1.75%
910.43
-16.24
-1.75%
926.67927.99930.54910.08
SIXV
Health care
SIXV
Health care
SIXV
-1.01%
1,474.50
-15.11
-1.01%
1,489.611,499.051,499.051,474.35
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,405.87
-17.39
-0.72%
2,423.262,438.162,443.462,399.83
F98:FRA
CytoMed Therapeutics Ltd
€0.82
+3.16%
(+0.025) 1D
Apr 21, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for F98...
Open
€0.82
High
€0.82
Low
€0.82
Mkt. cap
12.07M
Avg. vol.
4.00
Volume
0.00
52-wk high
€3.10
52-wk low
€0.62
No. of employees
42
News stories
From sources across the web
About CytoMed Therapeutics Ltd
CEO-
Employees42
Founded2018
Headquarters-
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SGD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
225.34K
225.34K
205.08K
205.08K
Cost of goods sold
12.89K
12.89K
31.99K
31.99K
Cost of revenue
12.89K
12.89K
31.99K
31.99K
Research and development expenses
581.23K
581.23K
527.51K
527.51K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
200.20K
200.20K
294.91K
294.91K
Operating expense
1.23M
1.23M
1.27M
1.27M
Total operating expenses
1.24M
1.24M
1.30M
1.30M
Operating income
-1.02M
-1.02M
-1.10M
-1.10M
Other non operating income
-38.16K
-38.16K
31.60K
31.60K
EBT including unusual items
-1.12M
-1.12M
-875.25K
-875.25K
EBT excluding unusual items
-1.12M
-1.12M
-1.02M
-1.02M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
221.94K
221.94K
370.51K
370.51K
Net income
-1.12M
-1.12M
-868.35K
-868.35K
Net profit margin
-497.85%
-497.85%
-423.42%
-423.42%
Earnings per share
-
-
-
-
Interest and investment income
42.90K
42.90K
19.05K
19.05K
Interest expense
-5.16K
-5.16K
-5.30K
-5.30K
Net interest expenses
37.74K
37.74K
13.75K
13.75K
Depreciation and amortization charges
40.14K
40.14K
58.31K
58.31K
EBITDA
-929.20K
-929.20K
-995.61K
-995.61K
Gain or loss from assets sale
122.00
122.00
-122.00
-122.00
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more